<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">        <PMID Version="1">30349348</PMID>        <DateRevised>            <Year>2018</Year>            <Month>11</Month>            <Day>14</Day>        </DateRevised>        <Article PubModel="Electronic-eCollection">            <Journal>                <ISSN IssnType="Print">1178-7074</ISSN>                <JournalIssue CitedMedium="Print">                    <Volume>11</Volume>                    <PubDate>                        <Year>2018</Year>                    </PubDate>                </JournalIssue>                <Title>International journal of general medicine</Title>                <ISOAbbreviation>Int J Gen Med</ISOAbbreviation>            </Journal>            <ArticleTitle>Primary hepatocellular carcinoma in a patient with history of treated breast cancer: a case report with challenging diagnosis and treatment.</ArticleTitle>            <Pagination>                <MedlinePgn>399-403</MedlinePgn>            </Pagination>            <ELocationID EIdType="doi" ValidYN="Y">10.2147/IJGM.S176052</ELocationID>            <Abstract>                <AbstractText Label="Introduction" NlmCategory="UNASSIGNED">Breast cancer is the most common malignancy in women worldwide. Long-term survivors among patients treated for breast cancer are at a high risk for developing a second primary malignancy. Hepatocellular carcinoma is the most frequent primary hepatic malignancy and should be ruled out in breast cancer patients who are diagnosed with solitary hepatic lesions. False diagnosis may lead to inappropriate oncologic staging and treatment of the disease.</AbstractText>                <AbstractText Label="Case presentation" NlmCategory="UNASSIGNED">We present the case of a 73-year-old female patient who had been treated for invasive ductal breast cancer 7 years ago and was diagnosed with a solid hepatic lesion at segments VI and VII and a small, calcified lesion at the tail of the pancreas on follow-up with an abdominal computed tomography. Oncology council decided that both lesions could be resected after determining whether they were metastatic or second primary malignancies. The patient underwent laparotomy and rapid biopsy which showed primary hepatocellular carcinoma and fibrosis of the pancreas. We performed hepatic segmentectomy (VI-VII) and cholecystectomy, while the pancreatic lesion was left intact. The postoperative course of the patient was uncomplicated and she remains disease free 2 years after the operation without any adjuvant therapy.</AbstractText>                <AbstractText Label="Conclusion" NlmCategory="UNASSIGNED">All hepatic lesions detected in breast cancer patients should be evaluated with open mind and liver biopsy should be performed to get a definitive diagnosis and implement the proper treatment strategy.</AbstractText>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Kosmidis</LastName>                    <ForeName>Christoforos</ForeName>                    <Initials>C</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Surgery, Interbalkan European Medical Center, Thessaloniki, Greece.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Varsamis</LastName>                    <ForeName>Nikolaos</ForeName>                    <Initials>N</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Surgery, Interbalkan European Medical Center, Thessaloniki, Greece.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Anthimidis</LastName>                    <ForeName>Georgios</ForeName>                    <Initials>G</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Surgery, Interbalkan European Medical Center, Thessaloniki, Greece.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Baka</LastName>                    <ForeName>Sofia</ForeName>                    <Initials>S</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Oncology, Interbalkan European Medical Center, Thessaloniki, Greece.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Valoukas</LastName>                    <ForeName>Dimitrios</ForeName>                    <Initials>D</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Oncology, General Hospital of Ptolemaida, Ptolemaida, Greece.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Koletsa</LastName>                    <ForeName>Triantafyllia</ForeName>                    <Initials>T</Initials>                    <AffiliationInfo>                        <Affiliation>Pathology Department, Faculty of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Zarampouka</LastName>                    <ForeName>Katerina</ForeName>                    <Initials>K</Initials>                    <AffiliationInfo>                        <Affiliation>Pathology Department, Faculty of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Koimtzis</LastName>                    <ForeName>Georgios</ForeName>                    <Initials>G</Initials>                    <AffiliationInfo>                        <Affiliation>Third Surgical Department, Faculty of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Georgakoudi</LastName>                    <ForeName>Eleni</ForeName>                    <Initials>E</Initials>                    <AffiliationInfo>                        <Affiliation>Aristotle University of Thessaloniki, Thessaloniki, Greece.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Zarogoulidis</LastName>                    <ForeName>Paul</ForeName>                    <Initials>P</Initials>                    <AffiliationInfo>                        <Affiliation>Pulmonary-Oncology Unit, &quot;Theageneio&quot; Cancer Hospital, Thessaloniki, Greece, pzarog@hotmail.com.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Efthymiadis</LastName>                    <ForeName>Christoforos</ForeName>                    <Initials>C</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Surgery, Interbalkan European Medical Center, Thessaloniki, Greece.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>            </PublicationTypeList>            <ArticleDate DateType="Electronic">                <Year>2018</Year>                <Month>10</Month>                <Day>11</Day>            </ArticleDate>        </Article>        <MedlineJournalInfo>            <Country>New Zealand</Country>            <MedlineTA>Int J Gen Med</MedlineTA>            <NlmUniqueID>101515487</NlmUniqueID>            <ISSNLinking>1178-7074</ISSNLinking>        </MedlineJournalInfo>        <CommentsCorrectionsList>            <CommentsCorrections RefType="Cites">                <RefSource>HPB (Oxford). 2007;9(3):166-73</RefSource>                <PMID Version="1">18333217</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Care (Basel). 2010;5(3):170-173</RefSource>                <PMID Version="1">21048832</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Oncogene. 2015 Aug 27;34(35):4635-46</RefSource>                <PMID Version="1">25486426</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>World J Hepatol. 2015 Nov 18;7(26):2648-63</RefSource>                <PMID Version="1">26609342</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Hepatocell Carcinoma. 2016 Oct 05;3:41-53</RefSource>                <PMID Version="1">27785449</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Transl Med. 2015 Feb 15;13:64</RefSource>                <PMID Version="1">25885919</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Gastroenterol Hepatol (N Y). 2015 Apr;11(4):253-5</RefSource>                <PMID Version="1">27099597</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer (Auckl). 2015 Sep 01;9(Suppl 1):23-34</RefSource>                <PMID Version="1">26380552</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Br J Cancer. 2008 Mar 11;98(5):870-4</RefSource>                <PMID Version="1">18268495</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Int J Surg Case Rep. 2016;27:198-201</RefSource>                <PMID Version="1">27661665</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Genomics Proteomics. 2012 Sep-Oct;9(5):311-20</RefSource>                <PMID Version="1">22990110</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Ann Surg. 2016 Jul;264(1):147-154</RefSource>                <PMID Version="1">26445472</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Hepatobiliary Pancreat Surg. 1998;5(2):165-72</RefSource>                <PMID Version="1">9745083</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>HPB (Oxford). 2011 Apr;13(4):272-8</RefSource>                <PMID Version="1">21418133</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>World J Hepatol. 2015 Nov 8;7(25):2578-89</RefSource>                <PMID Version="1">26557950</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Semin Intervent Radiol. 2013 Mar;30(1):56-66</RefSource>                <PMID Version="1">24436518</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer Res Treat. 2006 Mar;96(1):53-62</RefSource>                <PMID Version="1">16319993</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Mol Clin Oncol. 2014 May;2(3):331-336</RefSource>                <PMID Version="1">24772296</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>PLoS One. 2016 Jan 14;11(1):e0139782</RefSource>                <PMID Version="1">26766567</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Semin Intervent Radiol. 2013 Mar;30(1):3-11</RefSource>                <PMID Version="1">24436512</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>HPB (Oxford). 2016 Aug;18(8):700-5</RefSource>                <PMID Version="1">27485066</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Korean Med Sci. 2017 Feb;32(2):315-320</RefSource>                <PMID Version="1">28049244</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nihon Shokakibyo Gakkai Zasshi. 1978 Jan;75(1):71-9</RefSource>                <PMID Version="1">642220</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Br J Cancer. 2003 Jul 21;89(2):284-90</RefSource>                <PMID Version="1">12865918</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Biomed Rep. 2014 Mar;2(2):177-182</RefSource>                <PMID Version="1">24649092</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Epidemiol Biomarkers Prev. 2007 Mar;16(3):566-71</RefSource>                <PMID Version="1">17372253</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Oncology (Williston Park). 2005 Nov;19(12):1583-7; discussion 1587-8, 1590 passim</RefSource>                <PMID Version="1">16396152</PMID>            </CommentsCorrections>        </CommentsCorrectionsList>        <KeywordList Owner="NOTNLM">            <Keyword MajorTopicYN="N">breast cancer</Keyword>            <Keyword MajorTopicYN="N">hepatocellular cancer</Keyword>            <Keyword MajorTopicYN="N">microwave tissue coagulator</Keyword>            <Keyword MajorTopicYN="N">rapid biopsy</Keyword>            <Keyword MajorTopicYN="N">second primary malignancy</Keyword>        </KeywordList>        <CoiStatement>Disclosure The authors report no conflicts of interest in this work.</CoiStatement>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>10</Month>                <Day>24</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>10</Month>                <Day>24</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>10</Month>                <Day>24</Day>                <Hour>6</Hour>                <Minute>1</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>epublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30349348</ArticleId>            <ArticleId IdType="doi">10.2147/IJGM.S176052</ArticleId>            <ArticleId IdType="pii">ijgm-11-399</ArticleId>            <ArticleId IdType="pmc">PMC6188071</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>